LECTURES & PUBLICATIONS
Article 35 of the Geneva protocols, signed by 150 countries in 1949 and an additional protocol signed from 1977 onwards prohibited the use of weapons that cause and inflict unnecessary injury and suffering. In the recent wars such as Bosnia, Kosovo and the Gulf War, more than 31,000 missiles were launched against enemy lines containing DU and more than 300 tonnes of DU during the Gulf War alone.
DU is a radioactive and toxic element. In humans it can cause lung cancer, damage to the liver and kidney affecting the bone marrow and consequently destroying stem cells that form the white cells resulting in mutations and the long lasting effect of genetic damage.
LYMPHOSCINTOGRAPHY AND LYMPHOBIOPSY FOR BREAST CANCER AND MELANOMA: ABSTRACT OF NINE YEARS OF RESEARCH
Research and Development of the Gamma Radiation Surgical Probe
Utilized for the Surgical Procedure of Lymphobiopsy in Melanoma and Breast Cancer
REDUCING TECHNOLOGISTS EXPOSURE TO RADIOACTIVITY USING THE A.L.A.R.A. PRINCIPLE IN NUCLEAR MEDICINE
Improvements in nuclear medicine in the last 15 years have seen the widespread introduction of new techniques and imaging capabilities, and consequently, manufacturers from the USA, Europe, Japan and Korea are developing and delivering more sophisticated equipment which further demands new techniques in radiation protection.
Intel & The Pentagon
Currently there is a global component shortage, we are sharing this short clip about a new deal between Intel & the Pentagon to bolster domestic chip manufacturing in the US. As an Australian organization investing in R&D to bring new technology to Australia and the world, we are following this one with interest…
The world’s top semiconductor maker has been tapped by the U.S. Department of Defense to help develop next-generation electronic components for both commercial and national security purposes.
Intel announced that it was named to lead the first phase of the Pentagon’s Rapid Assured Microelectronics Prototypes-Commercial, or RAMP-C, program, which aims to establish a domestic manufacturing ecosystem for vital electronics.
Under the award, the Silicon Valley chip giant will work with IBM, Cadence, Synopsys, and other companies on the capabilities needed to develop and fabricate chips using Intel’s most advanced process technology.
The RAMP program, launched in late 2020, follows years of concerns about global chip production shifting from Western nations to contract manufacturers in Asia. The latest announcement, however, also comes amid a highly publicized shortage of semiconductors that has particularly hammered the auto industry. The White House is seeking more than $2 billion in Pentagon funding to bolster the U.S. microelectronics sector, and the Wall Street Journal reported that Intel discussed its efforts with administration officials last month.
Intel formed a standalone chip foundry subsidiary earlier this year amid plans to invest $20 billion in two new semiconductor factories in Arizona.
The company reportedly hopes to begin planning and construction on those facilities before the end of the year.
CNBC’s Josh Lipton reports on headlines that Intel plans to spend $20 billion to build two new chip plants in Arizona and to make other steps to boost domestic chip manufacturing
Credit: (Szal, 2021)
Szal, A., 2021. Thomas Net. [Online]
Available at: https://www.thomasnet.com/insights/intel-to-bolster-domestic-chip-manufacturing-with-pentagon-deal/?ecms_id=8a1411f9-12ab-4b01-8057-a44f7c59934d&ecms_short=ART5743&doc_type=ted_video_article&parent_id=c3757a3c-a56c-4bfe-bb65-cae47bb78e68&utm_content=featu
[Accessed 4th October 2021].
The Original Gammaprobe – Published by Australia/New Zealand Society of Nuclear Medicine, Septmeber 1998
Today the Gammaprobe is manufactured around the world by many different organisations, but have you ever wondered where the GammaProbe originated?
Dr. Ferradas paper details how Globalsonics revolutionized the lymphobiopsy technique in breast cancer.
Hyperthyroidism is the most common endocrinopathy of domestic cats. It is usually the result of thyroid adenoma(s) or multiple hyperplasic nodules which may unilateral or bilateral. Not all nodules are palpable. Functional thyroid tissue may elaborate increased amounts of thyroxine (T4) and T3, producing clinical signs including (i) a loud and fast heart, (ii) a prominent precordial impulse, (iii) a strong pulse and (iv) weight loss and good appetite. Heat tolerance, behavioural changes and polydipsia/polyuria can also be evident. Left untreated, hyperthyroidism damages a variety of end organs, particularly the heart and kidneys. The resulting catabolic state likely foreshortens life expectancy.
This study sought to evaluate how Australian veterinarians approach management and monitoring of feline hyperthyroidism and compare these results with a similar survey recently performed in the UK.
An invitation to complete an online survey was sent to veterinarians in all states and territories of Australia. The survey comprised questions relating to management of hyperthyroidism, use of antithyroid drugs vs radioiodine treatment vs surgical thyroidectomy, in addition to demographic information for respondents.
A total of 546 clinicians completed the survey. The most commonly preferred treatments for long-term management of feline hyperthyroidism were antithyroid medications (305/546; 56%) and radioiodine (210/546; 38%), with substantially more respondents selecting radioiodine when cost was removed as a consideration (425/546; 78%). However, most respondents had treated or referred few cases for radioiodine (median 2). Most veterinarians (500/546; 92%) used antithyroid medications either long term or prior to definitive treatment of hyperthyroidism. For medical management, 45% (244/546) of veterinarians used twice-daily carbimazole. Half of respondents (274/546) aimed to maintain the total thyroxine concentration anywhere within the laboratory reference interval in hyperthyroid cats without chronic kidney disease. Blood pressure monitoring was uncommon. Surgical thyroidectomy was rarely performed.
Conclusions and relevance
Radioiodine was more frequently preferred by Australian veterinarians compared wit those in the UK, likely associated with greater availability, reduced cost and shorter hospitalisation times in this jurisdiction, although antithyroid medications were the most frequently used treatment modality. Barriers remain to its utilisation, however, including perceived cost, misconceptions with regard to expected success rate and accessibility. Recent changes to recommendations on the management and monitoring of hyperthyroid cats do not appear to have been widely adopted by veterinarians at this time.
Nuclear Energy for Power and Nuclear for Medicine